EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT EYEPOINT PHARMACEUTICALS, INC.

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT)
Listen to this Section


$11.89
-0.3750 ( -3.06% ) 323.8K

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Market Data


Open $11.89
Previous Close $12.26
Volume 323.8K
Market Cap $1.03B
Day Range $11.82 - $12.45
52 Week Range $7.94 - $19.11
Shares Outstanding 83.84M
Change % -3.06%
Net Change ▼ -0.3750
Insider Ownership -0.01%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2005
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -1,310,968.00

Date Type Amount Purchased Purchaser
2025-05-19 Buy 5000.00 Zaderej Karen L.
2025-05-15 Buy 5000.00 Zaderej Karen L.
2024-08-21 Buy 12500.00 Zaderej Karen L.
2024-08-21 Buy 5000.00 ANDO GORAN
2024-08-21 Buy 2567.00 DICICCO WENDY F
2024-08-20 Buy 3173.00 Lurker Nancy
2024-07-26 Sale -1558.00 Lurker Nancy
2024-07-16 Sale -3250.00 GUYER DAVID R
2024-07-12 Sale -16666.00 Duker Jay S.
2024-07-12 Sale -11111.00 Lurker Nancy

SEC Filings


Form Type Description Pages Date
8-k/a 8K-related 39 Jul 29, 2025
4 Insider transactions 1 Jul 11, 2025
4 Insider transactions 1 Jul 11, 2025
4 Insider transactions 1 Jul 11, 2025
4 Insider transactions 1 Jul 02, 2025
4 Insider transactions 1 Jun 25, 2025
8-k 8K-related 11 Jun 20, 2025

Latest News


× Before browsing our site, please accept our cookies policy